Product information and disease descriptionPlace of product in therapyDisease description
Natural history, survival, and mortality
11 evidence topics · 9 sources
Lifelong course with associated morbidity
No cure: management aims
“Psoriasis cannot currently be cured, but management should aim to minimise physical and psychological harm by treating patients early in the disease process, identifying and preventing associated multimorbidity, instilling lifestyle modifications, and employing a personalised approach to treatment.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Age at onset: bimodal distribution
“Findings revealed consistency across studies about the bimodal age pattern of the onset of the disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“When we examined the incidence of psoriasis by sex and age bands, the two peaks for age at onset in women were more frequently around 18-29 and 50-59 years, whereas in men they occurred more frequently around 30-39 and 60-69 or 70-79 years.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Age at diagnosis, 1970 to 1999
“The mean age at diagnosis (± standard deviation) of psoriasis was 43.2 ± 17.0 years and 828 (51.0%) subjects were male (Table 1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Average age at incidence increased across the three decades from 39.8 years in 1970–1979, to 41.9 years in 1980–1989 and 45.5 years in 1990–1999 (p<0.001).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Progression between clinical forms and erythroderma
“Patients with guttate psoriasis may later develop plaque psoriasis. In rare cases of severe uncontrolled disease, psoriasis causes a widespread erythematous rash (erythroderma) that is life-threatening due to potential complications including hypothermia, risk of infection, acute kidney injury and high-output cardiac failure.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Mortality and life expectancy in severe psoriasis
“There was no overall effect of mild psoriasis on mortality (HR, 1.0; 95% confidence interval [CI], 0.97-1.02), whereas patients with severe psoriasis demonstrated an increased overall mortality risk (HR, 1.5; 95% CI, 1.3-1.7).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Male and female patients with severe psoriasis died 3.5 (95% CI, 1.2-5.8) and 4.4 (95% CI, 2.2-6.6) years younger, respectively, than patients without psoriasis (P < .001).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cause-specific mortality and age at death in severe psoriasis
“Patients with severe psoriasis were at increased risk of death from cardiovascular disease (HR 1.57; 95%CI 1.26–1.96), malignancies (HR 1.41; 95%CI 1.07–1.86), chronic lower respiratory disease (HR 2.08; 95%CI 1.24–3.48), diabetes (HR 2.86; 95%CI 1.08–7.59), dementia (HR 3.64; 95%CI 1.36–9.72), infection (HR 1.65; 95%CI 1.26–2.18), kidney disease (HR 4.37; 95%CI 2.24–8.53), and unknown/missing causes (HR 1.44; 95%CI 1.09–1.88).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, psoriasis patients died at a younger age than unexposed patients (mean age of 73 vs 79 years respectively, p<0.001), as shown graphically in Figure 1.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cardiovascular mortality in severe psoriasis
“Severe psoriasis was an independent risk factor for CV mortality (HR 1.57; 95% CI 1.26, 1.96) when adjusting for age, sex, smoking, diabetes, hypertension, and hyperlipidaemia. Overall, severe psoriasis patients experienced one extra CV death per 283 patients per year, even when adjusting for major CV risk factors.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For example, the RR of CV death for a 40-year-old and 60-year-old with severe psoriasis was 2.69 (1.45, 4.99) and 1.92 (1.41, 2.62), respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
All-cause and cardiovascular mortality by severity: meta-analysis of 12 studies
“We included 12 studies. The pooled RRs for all-cause mortality were 1.21 (95% CI 1.14-1.28) in psoriasis, 1.13 (95% CI 1.09-1.16) in mild psoriasis, and 1.52 (95% CI 1.35-1.71) in severe psoriasis. The pooled RRs for cardiovascular mortality were 1.15 (95% CI 1.09-1.21) in psoriasis, 1.05 (95% CI 0.92-1.20) in mild psoriasis, and 1.38 (95% CI 1.09-1.74) in severe psoriasis.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“For noncardiovascular causes, mortality risk from liver disease, kidney disease, and infection was significantly increased in psoriasis, regardless of disease severity.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
All-cause mortality over a median follow-up of 52.3 months
“Over an average median follow-up of 52.3 months, psoriasis was significantly associated with increased mortality risk (HR, 1.99; 95% CI, 1.01-3.93; P = .047) with adjustment for demographics, smoking, and comorbidities including cardiovascular disease, diabetes, chronic obstructive pulmonary disease, cancer, chronic kidney disease, and stroke.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Survival compared with the Minnesota white population
“Survival in the overall psoriasis cohort was similar to that expected in the Minnesota white population (standardized mortality ratio [SMR]: 0.95, 95% CI: 0.84, 1.07, p=0.36) over the entire time period.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote